Benzinga | May 13, 2021 04:25PM EDT

Marrone Bio Innovations Q1 EPS $(0.02) Beats $(0.03) Estimate, Sales $11.00M Miss $11.22M Estimate

Marrone Bio Innovations (NASDAQ:MBII) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 60 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $11.00 million which missed the analyst consensus estimate of $11.22 million by 1.96 percent. This is a 13.99 percent increase over sales of $9.65 million the same period last year.